Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea

2 abstracts

Abstract
Personalized neoadjuvant strategy in ER positive and HER2 negative breast cancer to increase BCS rate (PLATO): A prospective, multicenter, phase II clinical trial.
Org: Seoul National University Hospital, Seoul National University College of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul National University Bundang Hospital,
Abstract
Selective avoidance of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with HER-2 positive/triple negative breast cancer: Prospective, multi-center, single-arm study (ASLAN).
Org: Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, Department of Surgery and Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea, Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea, Gangnam Severance Hospital, Seoul, NA, Korea, Republic of (South), Division of Breast, Department of Surgery , College of Medicine, University of Ulsan, Seoul, South Korea,